Compare PTGX & AVPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PTGX | AVPT |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | United States | United States |
| Employees | N/A | 2934 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 2.3B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | AVPT |
|---|---|---|
| Price | $98.86 | $10.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 11 |
| Target Price | ★ $106.67 | $16.64 |
| AVG Volume (30 Days) | 709.8K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $867.86 | $24.07 |
| Revenue Next Year | N/A | $19.59 |
| P/E Ratio | ★ N/A | $1,348.94 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $39.60 | $9.86 |
| 52 Week High | $105.69 | $20.25 |
| Indicator | PTGX | AVPT |
|---|---|---|
| Relative Strength Index (RSI) | 62.54 | 39.36 |
| Support Level | $76.63 | $9.86 |
| Resistance Level | N/A | $11.42 |
| Average True Range (ATR) | 4.83 | 0.34 |
| MACD | 0.45 | 0.02 |
| Stochastic Oscillator | 61.78 | 14.34 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.